Vaughn, John L. http://orcid.org/0000-0001-8122-3852
Brown, Samantha http://orcid.org/0000-0001-5352-974X
Papadopoulos, Esperanza B.
Jakubowski, Ann A.
Tamari, Roni http://orcid.org/0000-0002-2386-0850
Giralt, Sergio A. http://orcid.org/0000-0003-1944-5053
Ponce, Doris M. http://orcid.org/0000-0002-9422-5766
Cho, Christina http://orcid.org/0000-0002-7964-3011
Perales, Miguel-Angel http://orcid.org/0000-0002-5910-4571
Shaffer, Brian C.
Gyurkocza, Boglarka http://orcid.org/0000-0002-2933-2119
Article History
Received: 6 July 2022
Revised: 28 July 2022
Accepted: 5 August 2022
First Online: 8 September 2022
Competing interests
: SAG receives research funding from Miltenyi Biotec, Takeda Pharmaceutical Co., Celgene Corp., Amgen Inc., Sanofi, Johnson and Johnson, Inc., Actinium Pharmaceuticals, Inc., and is on the Advisory Boards for: Kite Pharmaceuticals, Inc., Celgene Corp., Sanofi, Novartis, Johnson and Johnson, Inc., Amgen Inc., Takeda Pharmaceutical Co., Jazz Pharmaceuticals, Inc., Actinium Pharmaceuticals, Inc. MAP reports honoraria from Abbvie, Allovir, Astellas, Bristol-Myers Squibb, Celgene, Equilium, Exevir, Incyte, Karyopharm, Kite/Gilead, Merck, Miltenyi Biotec, MorphoSys, Novartis, Nektar Therapeutics, Omeros, OrcaBio, Takeda, and VectivBio AG, Vor Biopharma. He serves on DSMBs for Cidara Therapeutics, Medigene, Sellas Life Sciences, and Servier, and the scientific advisory board of NexImmune. He has ownership interests in NexImmune and Omeros. He has received institutional research support for clinical trials from Incyte, Kite/Gilead, Miltenyi Biotec, Nektar Therapeutics, and Novartis. BCS reports consulting for Hansa Biopharma and Gamida Cell. BG has received institutional research support for clinical trials from Actinium Pharmaceuticals.